4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-037366
Director sold 8,000 shares at $6.97 ($55,760)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Griggs Jonathan Director | 2017-05-31 | Sale | −8,000 | $6.97 | $55,760 | 10,803 | D |
| Open-market sales · 8,000 sh · avg $6.97 · $55,760 | |||||||
Loading xslF345X03/doc4.xml…